Literature DB >> 1660808

Specificity of new peptide immunoassays versus other immunoassays and agglutination tests for detection of HIV antibody in African sera.

G Léonard1, M Verdier, A Sangaré, J L Rey, F Denis.   

Abstract

The specificity of three HIV EIAs using synthetic peptides was evaluated and compared with that of four commercial EIAs using recombinant proteins or whole virus lysates of HIV-1 or of HIV-1 and HIV-2, and of two tests based on agglutination of sensitized particles. A total of 734 West African sera were screened. The best results were obtained with tests using recombinant proteins. HIV tests using synthetic peptides able to distinguish between HIV-1 and HIV-2 antibodies showed comparable specificity, but some false negative results represent a major handicap of these peptide EIAs in screening for HIV antibodies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660808     DOI: 10.1007/bf01975815

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  20 in total

1.  Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes.

Authors:  B H Hahn; M A Gonda; G M Shaw; M Popovic; J A Hoxie; R C Gallo; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

2.  A STLV-III related human retrovirus, HTLV-IV: analysis of cross-reactivity with the human immunodeficiency virus (HIV).

Authors:  F Barin; F Denis; A Baillou; G Leonard; M Mounier; S M'Boup; G Gershy-Damet; A Sangare; P Kanki; M Essex
Journal:  J Virol Methods       Date:  1987-08       Impact factor: 2.014

3.  Discrimination between antibodies to HIV and to related retroviruses using site-directed serology.

Authors:  E Norrby; G Biberfeld; F Chiodi; A von Gegerfeldt; A Nauclér; E Parks; R Lerner
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

4.  Multicenter evaluation of a new recombinant enzyme immunoassay for the combined detection of antibody to HIV-1 and HIV-2.

Authors:  L Ayres; F Avillez; A Garcia-Benito; F Deinhardt; L Gürtler; F Denis; G Léonard; S Ranger; P Grob; H Joller-Jemelka
Journal:  AIDS       Date:  1990-02       Impact factor: 4.177

5.  Enzyme immunoassay using a novel recombinant polypeptide to detect human immunodeficiency virus env antibody.

Authors:  R M Thorn; G A Beltz; C H Hung; B F Fallis; S Winkle; K L Cheng; D J Marciani
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

6.  Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection.

Authors:  R S Smith; R B Naso; J Rosen; A Whalley; Y L Hom; K Hoey; C J Kennedy; J A McCutchan; S A Spector; D D Richman
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

7.  Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate.

Authors:  P Kumar; H X Hui; J C Kappes; B S Haggarty; J A Hoxie; S K Arya; G M Shaw; B H Hahn
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

8.  Comparison of six serological assays for human immunodeficiency virus antibody detection in developing countries.

Authors:  P Van de Perre; D Nzaramba; S Allen; C H Riggin; S Sprecher-Goldberger; J P Butzler
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

9.  Comparison of 10 enzyme immunoassays for detection of antibody to human immunodeficiency virus type 2 in West African sera.

Authors:  F Denis; G Leonard; A Sangare; G Gershy-Damet; J L Rey; B Soro; D Schmidt; M Mounier; M Verdier; A Baillou
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

10.  Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus.

Authors:  J W Gnann; P L Schwimmbeck; J A Nelson; A B Truax; M B Oldstone
Journal:  J Infect Dis       Date:  1987-08       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.